National Cancer Institute; Notice of Closed Meeting, 12889-12890 [05-5163]

Download as PDF 12889 Federal Register / Vol. 70, No. 50 / Wednesday, March 16, 2005 / Notices Dated: March 10, 2005. Betsey Dunaway, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 05–5143 Filed 3–15–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; Comment Request; Revision of OMB# 0925–0002 Ruth L. Kirschstein NRSA Individual Fellowship Application SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Office of Extramural Research, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Proposed Collection: Title: Ruth L. Kirschstein NRSA Individual Fellowship Application. Type of Information Collection Request: Revision of a currently approved collection. Form Numbers: The PHS 416–1, 416–9, 416–5, 416–6031, 6031–1, Need and Use of Information Collection: The PHS 416–1 and 416–9 are used by individuals to apply for direct research training support. Awards are made to individual applicants for specified training proposals in biomedical and behavioral research, selected as a result of a national competition. The other related forms (PHS 416–5, 416–7, 6031, 6031–1) are used by these individuals to activate, terminate, and provide for payback of a National Research Service Award. Affected Public: Individuals or households; business or other for profit; not-for-profit institutions; Federal Government; and State, Local or Tribal government. Type of Respondents: Adult scientific trainees and professionals. The annual reporting burden is represented in the following table: Estimated number of respondents Estimated number of responses per respondent Average burden hours per response Estimated total annual burden hours requested Applicants ........................................................................................................ Referee ............................................................................................................ 81,837.60 7,268.56 1.0834 1.0834 2.658 2.658 235,665.86 20,931.11 Totals ........................................................................................................ 89,106.16 1.0834 2.658 256,596.97 Type of respondents There are no Capital Costs to report. There are no Operating or Maintenance Costs to report. Request For Comments: Written comments and/or suggestions from the public and affected agencies should address one or more of the following points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriated automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Ms. Mikia Currie Division of Grants Policy for Extramural Research Administration, NIH, Rockledge 1 Suite 350, Room 3505, 6705 Rockledge Drive, Bethesda, MD 20892– 7974, or call non-toll-free number (301) 435–0941 or E-mail your request, FOR FURTHER INFORMATION CONTACT: VerDate jul<14>2003 16:45 Mar 15, 2005 Jkt 205001 including your address to: curriem@od.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Dated: March 7, 2005. Joe Ellis, Acting Director for OPERA. [FR Doc. 05–5200 Filed 3–15–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of the meeting of the President’s Cancer Panel. The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as amended, because the premature disclosure of information and the discussions would be likely to significantly frustrate implementation of recommendations. Name of Committee: President’s Cancer Panel. Date: March 30, 2005. PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Time: 1 p.m. to 3 p.m. Agenda: The Panel will review the first draft of the upcoming PCP annual report on ‘‘Translating Research to Reduce the Burden of Cancer.’’ Place: National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Building 6116, Room 212, Bethesda, MD 20892, (Teleconference). Contact Person: Abby B. Sandler, PhD, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Building 6116, Room 212, Bethesda, MD 20892, 301/451–9399. This meeting is being published less than 15 days prior to the meeting due to scheduling conflicts. Any interested person may file written comments with the committee by forwarding the comments to the Contact Person listed on this Notice. The comments should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.deainfo.nci.nih.gov/advisory/pcp/ pcp.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93,397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) E:\FR\FM\16MRN1.SGM 16MRN1 12890 Federal Register / Vol. 70, No. 50 / Wednesday, March 16, 2005 / Notices Dated: March 10, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–5163 Filed 3–15–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Review of Research Applications (R01s). Date: April 7, 2005. Time: 10 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Patricia A. Haggerty, PhD, Scientific Review Administrator, National Heart, Lung, and Blood Institute/NIH, Clinical Studies & Training Studies Rev. Grp., Division of Extramural Affairs/Section Chief, 6701 Rockledge Drive, Room 7194, Bethesda, MD 20892, 301/435–0288. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Heart, Lung and Blood Institute Special Emphasis Panel, Review of Research Scientist Development Awards (K02s) and Clinical Investigator Awards (K08s). Date: April 7–8, 2005. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Zoe Huang, MD, Health Scientist Administrator, Review Branch, Room 7190, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7924, Bethesda, MD 20892– 7924, 301–435–0314. VerDate jul<14>2003 16:45 Mar 15, 2005 Jkt 205001 This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: March 10, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–5162 Filed 3–15–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meeting will be closed to the public in accordance with the provisions set forth in sections 552(b)(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel, Institutional Training and Career Development. Date: March 22, 2005. Time: 2 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Raul A. Saaverdra, PhD, Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research, NINDS/NIH/DHHS, NSC; 6001 Executive Blvd., Ste. 3208, Bethesda, MD 20892–9529, 301–496–9223, saavedrr@ninds.nih.gov. This notice is being published less than 15 day prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Neurological Disorders and Stroke Special PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Emphasis Panel, Research on Research Integrity Review. Date: March 30–31, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Lucerene Hotel, 201 West 79th Street, New York, NY 10024. Contact Person: Phillip F. Wiethorn, Scientific Review Administrator, DHHS/NIH/ NINDS/DER/SRB, 6001 Executive Boulevard, MSC 9529, Neuroscience Center, Room 3203, Bethesda, MD 20892–9529, 301–496–5388, wiethorp@ninds.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS). Dated: March 10, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–5160 Filed 3–15–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Migration and Reproductive Health Risks. Date: April 7, 2005. Time: 9:30 a.m. to 11 a.m. Agenda: To review and evaluate grant applications. Place: Four Points by Sheraton Bethesda, 8400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Kishena C. Wadhwani, PhD, MPH, Scientific Review Administrator, Division of Scientific Review, 9000 Rockville Pike, MSC 7510, 6100 Building, Room 5B01, Bethesda, MD 20892–7510, (301) 496–1485, wadhwank@mail.nih.gov. E:\FR\FM\16MRN1.SGM 16MRN1

Agencies

[Federal Register Volume 70, Number 50 (Wednesday, March 16, 2005)]
[Notices]
[Pages 12889-12890]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-5163]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. appendix 2), notice is hereby given of the meeting of 
the President's Cancer Panel.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as 
amended, because the premature disclosure of information and the 
discussions would be likely to significantly frustrate implementation 
of recommendations.

    Name of Committee: President's Cancer Panel.
    Date: March 30, 2005.
    Time: 1 p.m. to 3 p.m.
    Agenda: The Panel will review the first draft of the upcoming 
PCP annual report on ``Translating Research to Reduce the Burden of 
Cancer.''
    Place: National Cancer Institute, National Institutes of Health, 
6116 Executive Boulevard, Building 6116, Room 212, Bethesda, MD 
20892, (Teleconference).
    Contact Person: Abby B. Sandler, PhD, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, Building 6116, Room 212, Bethesda, MD 20892, 
301/451-9399.

    This meeting is being published less than 15 days prior to the 
meeting due to scheduling conflicts.
    Any interested person may file written comments with the 
committee by forwarding the comments to the Contact Person listed on 
this Notice. The comments should include the name, address, 
telephone number and, when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://www.deainfo.nci.nih.gov/advisory/pcp/pcp.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.


(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93,397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


[[Page 12890]]


    Dated: March 10, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-5163 Filed 3-15-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.